中化生

-1.05 (-3.02%)最後更新 2026-09-11

台灣 · 上市 · 生技醫療業

33.70151成交張數–本益比0.81股價淨值比0.00%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	44	32	26.5%	4.06	41.64	-1.6%	-1.2%	1.1	0.9
2026Q1	45	32	28.6%	3.02	41.34	-4.9%	-3.5%	0.9	0.9
2025Q4	43	31	28.5%	2.97	40.14	-7.6%	-5.4%	-0.2	-0.4
2025Q3	44	32	27.6%	3.34	41.78	-3.1%	-2.2%	1.1	1.0
2025Q2	46	33	29.0%	2.82	42.01	-2.1%	-1.4%	-0.3	-0.4
2025Q1	47	34	28.9%	2.88	43.52	0.6%	0.4%	0.8	0.5
2024Q4	48	34	29.5%	3.39	43.28	1.6%	1.1%	1.9	1.8
2024Q3	49	33	31.4%	2.81	43.04	2.9%	2.0%	0.6	0.4
2024Q2	50	33	33.0%	2.46	43.16	3.5%	2.4%	4.3	4.1
2024Q1	52	34	35.3%	2.16	43.58	3.7%	2.5%	-2.2	-2.7
2023Q4	52	34	35.2%	2.15	43.20	8.1%	5.4%	0.3	-0.1
2023Q3	50	33	34.3%	2.24	42.68	9.1%	6.1%	-2.5	-3.0
2023Q2	49	33	32.7%	2.46	42.74	12.7%	8.6%	1.3	1.0
2023Q1	50	34	32.1%	1.93	43.91	16.2%	10.8%	0.2	-3.1
2022Q4	46	32	30.0%	2.36	41.17	15.3%	10.4%	1.7	0.4
2022Q3	44	31	30.0%	2.29	39.98	16.5%	11.3%	1.2	0.8
2022Q2	44	30	32.1%	2.57	38.55	15.6%	11.0%	2.7	1.8
2022Q1	46	30	35.0%	1.76	38.34	15.4%	10.9%	1.7	0.6
2021Q4	44	29	33.9%	2.14	37.31	14.9%	10.7%	1.2	-0.1
2021Q3	42	28	34.0%	1.69	36.03	15.7%	11.3%	-0.2	-1.0
2021Q2	38	28	26.0%	2.22	36.10	13.8%	10.4%	-0.1	-1.8
2021Q1	33	26	20.9%	2.18	33.85	25.8%	17.8%	1.4	1.0
2020Q4	31	25	20.6%	2.50	32.21	23.6%	16.2%	-0.2	-0.4
2020Q3	30	24	19.5%	2.51	31.00	21.5%	14.9%	-0.0	-0.7
2020Q2	31	24	22.7%	2.16	30.64	21.3%	14.3%	1.1	0.5
2020Q1	34	20	40.7%	1.25	26.38	5.1%	3.1%	0.5	0.1
2019Q4	34	20	41.4%	1.19	25.98	5.9%	3.5%	0.6	0.4
2019Q3	33	20	40.8%	1.12	25.45	3.8%	2.3%	0.5	0.2
2019Q2	34	20	41.8%	0.96	25.16	14.4%	8.1%	1.0	0.8
2019Q1	33	20	38.6%	1.36	26.18	14.1%	8.2%	0.5	0.2
2018Q4	32	20	38.4%	1.44	25.58	12.3%	7.0%	0.2	-0.1
2018Q3	32	20	35.1%	1.99	26.42	15.0%	8.6%	0.2	-0.0
2018Q2	33	18	46.0%	1.30	23.29	7.3%	4.3%	0.5	0.2
2018Q1	33	18	44.9%	1.36	23.57	5.7%	3.4%	1.5	1.3
2017Q4	34	18	47.2%	1.27	23.48	4.8%	2.8%	1.0	-4.1
2017Q3	35	18	49.5%	0.74	22.79	3.8%	2.1%	0.5	-1.8
2017Q2	27	17	35.9%	1.45	22.06	1.1%	0.7%	-0.4	-0.8
2017Q1	27	18	33.8%	1.18	22.72	1.7%	1.1%	0.5	0.3
2016Q4	27	18	35.0%	1.19	22.83	–	–	1.0	0.8
2016Q3	27	17	36.4%	1.28	22.46	–	–	0.3	0.1